title: Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey.
abstract: The purpose of the EP wire is to examine the clinical practice in the management of sustained ventricular tachycardia (VT), with special focus on diagnostic and therapeutic strategies. Forty-five European centres, all members of the EHRA-EP Research network completed the questions of the survey. There was an equal distribution of centres with high, medium, and low volume of activity. The most common aetiologies were: post-myocardial infarction ischaemic heart disease (55%), followed by idiopathic dilated cardiomyopathy (18%), and idiopathic VT (11%) and others (12%). Cardiac magnetic resonance imaging was performed in more than 50% of patients in 24 centres (62.2%). Invasive electrophysiological study was performed in more than 70% of patients in 16 centres (35.6%), between 51 and 70% in 9 (20%), below 50% in 20 (44.5%). In 39 centres (86.7%), implantable cardioverter defibrillator implantation was considered in all patients with structural heart disease and left ventricular ejection fraction <35%. In the setting of secondary prevention, early radiofrequency ablation of the VT was performed in more than 50% of the patients in only five centres (11.4%). Sequential endo-epicardial approach was reported in 52.2% of centres.
authors: Cardiology Department of Cardiothoracic Science, University Hospital S. Maria della Misericordia, Udine, Italy. proclemer.alessandro@aoud.sanita.fvg.it
authors: Alessandro
authors: A
authors: Proclemer
authors: Nikolaos
authors: N
authors: Dagres
authors: Germanas
authors: G
authors: Marinskis
authors: Laurent
authors: L
authors: Pison
authors: Gregory Y H
authors: GY
authors: Lip
authors: Carina
authors: C
authors: Blomstrom-Lundqvist
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D057791:Cardiac Imaging Techniques; D002311:Cardiomyopathy, Dilated / Q000150:complications; D017115:Catheter Ablation; D017147:Defibrillators, Implantable; D005060:Europe; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009203:Myocardial Infarction / Q000150:complications; D017202:Myocardial Ischemia / Q000150:complications; D013318:Stroke Volume; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000601:surgery* / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents